Download PDFPDF

1295 Integrating drug structure and target binding affinity for improved prediction of survival in cancer patients treated with immune checkpoint inhibitors
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address